March 22, 2022
Moderna Makes Annual Booster Combo Respiratory Vaccine Targeting all Four Endemic HCoV
Moderna, Inc. (NASDAQ:MRNA) is expanding its mRNA pipeline with two new development programs. This announcement reflects the company’s commitment to expanding its portfolio by building on Moderna’s experience with Spikevax, its COVID-19 vaccine.